Sarnoff Foundation Inspiring the Physician-Scientists of TomorrowAbout Us
advanced search

David Kandzari, M.D.

Following undergraduate and medical training at Duke University and the Johns Hopkins Hospital, Dr. Kandzari returned to Duke as a fellow in general and interventional cardiology. Following his appointment as the John B. Simpson Assistant Professor in Interventional Cardiology and Genomic Sciences to the cardiology faculty in the Division of Cardiology and Department of Genetics at Duke University Medical Center and the Duke Clinical Research Institute, Dr. Kandzari worked with colleagues and industry to explore wide-ranging research interests, including the development of novel catheter-based technologies, diagnostic imaging with computed tomographic angiography and clinical trials evaluating anti-thrombotic and cardioprotective therapies in cardiovascular disease. In addition to his clinical and teaching responsibilities in coronary and peripheral vascular disease, he served as principal investigator and/or as a steering committee member to national clinical trials in addition to a number of investigator-initiated studies. He has published numerous manuscripts regarding therapies in the practice of interventional cardiology and acute coronary syndromes. In December 2006, Dr. Kandzari accepted a position as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company, where his responsibilities included oversight of clinical research, medical affairs programs and strategic development. In May 2008, Dr. Kandzari joined the United States Food and Drug Administration as a Medical Officer in the Center for Devices and Radiological Health. He is also recently joined the Scripps Clinic as Director of Interventional Cardiology Research and as a practicing clinician/researcher.
Print this page Email this page 
Sarnoff Cardiovascuar Research Foundation
731 G-2 Walker Road, Great Falls, VA 22066
P: (888) 4-SARNOFF or (703) 759-7600   -   F: (703) 759-7838   -   Email: